Homocysteine and initial stage of cardiovascular disease (Brief review of etiopathogenetic findings);Homocystein a iniciální stadium kardiovaskulárního onemocněrrí (stručný přehled etiopatogenetických poznatků)

Cesko-Slovenska Pediatrie

Volumn 56, Issue 6, 2001, Pages 356-361

  Palyzová, Daniela ^a   Hyanek J ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Oddeleni Klinicke Biochemie   (Czech Republic)

Author keywords

Atherosclerosis; Cardiovascular disease; Homocysteine; Primary hypertension

Indexed keywords

EID: 0039330592     PISSN: 00692328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Andersson, A., Brattström, L., Israelsson, B. et al.: The effect of excess daily methionine intake on plasma homocysteine after a methionine loading test in humans. Clin. Chim. Acta, 192, 1990, č. 1, s. 69-76.
2. Barker, D. J.: In utero programming of chronic disease. Clin. Sci., 95, 1998, č. 2, s. 115-128.
3. Barker, D. J.: The fetal origins of adult hypertension. J. Hypertension, 10, 1992, Suppl., č. 7, s. 39-44.
4. Barker, D. P. J., Shiell, W., Baker, M. E. et al.: Growth in utero and blood pressure in the next generation. J. Hypertension, 18, 2000, č. 4, s. 843-846.
5. Berenson, G. S., Srinivasan, S. R., Bao, W. et al.: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. New Engl. J. Med., 338, 1998, č. 23, s. 1650-1656.
6. Berenson, G. S., Srinivasan, S. R., Bao, W.: Precursors of cardiovascular risk in young adults from a biracial (black-white) population: the Bogalusa Heart Study. Ann. N. Y. Acad. Sci., 817, 1997, č. 28, s. 189-198.
7. Berenson, G. S., Wattigney, W. A., Bao, W., Srinivasan, S. R., Radhakrishnamurthy, B.: Rationale to study the early natural history of heart disease: the Bogalusa Heart Study. Amer. J. Med. Sci., 310, 1995, Suppl. 1, s. 22-28.
8. Berenson, G. S., Wattigney, W. A., Tracy, R. E. et al.: Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Amer. J. Cardiol., 70, 1992, č. 9, s. 851-858.
9. Bostom, A. G., Jacques, P. F., Nadeau, M. R. et al.: Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study. Atherosclerosis, 116, 1995, č. 1, s. 147-151.
10. Brattström, L., Lindgren, A., Israelsson, B. et al.: Hyperhomocysteinemia in stroke: prevalence, cause, and relationships to type of stroke and stoke risk factors. Eur. J. Clin. Invest., 22, 1992, č. 3, s. 214-221.
11. Brouwer, I. A., van-Dusseldorp, M., West, C. E. et al.: Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J. Nutr., 129, 1999, č. 6, s. 1135-1139.
12. De Laet, C., Wautrecht, J. C., Brasseur, D. et al.: Plasma homocysteine concentration in a Belgian school-age population. Amer. J. Clin. Nutr., 69, 1999, č. 5, s. 968-972.
13. Dudman, N. P. B.: An alternative view of homocysteine. Lancet, 354, 1999, č. 11, s. 2072-2074.
14. Fortin, L. J., Genest, J. Jr.: Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin. Biochem., 28, 1995, č. 2, s. 155-162.
15. Genest, J. J. Jr., McNanara, J. R., Upson, B. et al.: Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. Arteriosclerosis Thrombosis, 11, 1991, č. 5, s. 1129-1136.
16. Greenlund, K. J., Srinivasan, S. R., Xu, J. H. et al.: Plasma homocysteine distribution and its association with parental history of coronary artery disease in black and white children: the Bogalusa Heart Study. Circulation, 99, 1999, č. 16, s. 2144-2149.
17. Guttormsen, A. B., Ueland, P. M., Nesthus, I.: Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (>40 μmol/l): The Hordaland Homocysteine Study. J. Clin. Invest., 98, 1996, č. 9, s. 2174-2183.
18. Haust, M. D.: The genesis of atherosclerosis in pediatric age-group. Pediatr. Pathol., 10, 1990, č. 1, s. 253-271.
19. Heald, F. P.: Atheroclerosis during adolescence. Med. Clin. N. Amer., 74, 1990, č. 5, s. 1321-1332.
20. Hyánek, J., Brenner, H. J., Slavík, M. et al.: Mild hyperhomocysteinaemia in children born from families where parents or grandparents were operated on for peripheral artery or aortocoronary bypasses. Klin. Biochem. Metabol., 7 (28), 1999, č. 2, s. 77-81.
21. Hyánek, J., Stříbrný, J., Šebesta, P. a spol.: Hyperhomocysteinémie - rizikový faktor pro vznik cévních onemocnění nezávislý na hladinách lipidů. Čas. Lék. čes., 136, 1997, č. 23, s. 720-724.
22. Kanani, P. M., Sinkey, C. A., Browning, R. L. et al.: Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation, 100, 1999, č. 11, s. 1161-1168.
23. Kimm, S. Y., Payne, G. H., Stylíanou, M. P. et al.: National trends in the management of cardiovascular disease risk factors in children: second NHLBI survey of primary care physicians. Pediatrics, 102, 1998, č. 5, s. E50.
24. Komatsu, A., Sakurai, I.: A study of the development of atherosclerosis in childhood and young adults: risk factors and the prevention of progression in Japan and the USA. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Pathol. Int., 46, 1996, č. 8, s. 541-547.
25. Langley Evans, S. C., Sherman, R. C., Welham, S. J. et al.: Intrauterine programming of hypertension: the role of the renín-angiotensin system. Biochem. Soc. Trans., 27, 1999, č. 2, s. 88-93.
26. Lenfant, C., Savage, P. J.: The early natural history of atherosclerosis and hypertension in the young: National Institutes of health perspectives. Amer. J. Med. Sci., 310, 1995, Suppl. 1, s. 3-7.
27. Malinow, M. R.: Homocysteine and arterial occlusive diseases. J. Intern. Med., 236, 1994, č. 6, s. 603-617.
28. Malinow, M. R., Duell, P. B., Hess, D. L. et al.: Reduction of plasma homocyst(e)ine levels by breakfest cereal fortified with folic acid in patients with coronary heart disease. New Engl. J. Med., 338, 1998, č. 15, s. 1009-1015.
29. Malinow, M. R., Rajkovic, C., Duell, P. B. et al.: The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism. Amer. J. Obstet. Gynecol., 178, 1998, č. 2, s. 228-233.
30. Malinow, M. R.: Homocyst(e)ine, vitamins and genetical interactions in vascular disease. Canad. J. Cardiol., 15, 1999, Suppl. B, s. 31B-34B.
31. Mann, N. J., Dudman, N. P. B., Guo, X. W. et al.: The effect of the diet on homocysteine in healthy male subjects. Netherl. J. Med., 52, 1998, Suppl., s. 10.
32. Martyn, C. N., Greenwald, S. E.: Impaired synthesis of elastin in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension. Lancet, 350 (9082), 1997, s. 953-955.
33. McCully, K. S.: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Amer. J. Pathol., 56, 1969, č. 1, s. 111-128.
34. Melander, O., Mattiasson, I., Marsal, K. et al.: Heredity for hypertension influences intrauterine growth and the relation between fetal growth and adult blood pressure. J. Hypertension, 17, 1999, č. 11, s. 1557-1561.
35. Melnick, J. L., Adam, E., DeBakey, M. E.: Cytomegalovirus and atherosclerosis. Arch. Immunol. Ther. Exp. (Warsz.), 44, 1996, č. 5-6, s. 297-302.
36. Mendis, S., Athauda, S. B., Naser, M. et al.: Association between hyperhomocysteinemia and hypertension in Sri Lankans. J. Int. Med. Res., 27, 1999, č. 1, s. 38-44.
37. Miller, A. L., Kelly, G. S.: Methionine and homocysteine metabolism and the nutritional prevention of certain birth defects and complications of pregnancy. Alt. Med. Rev., 1, 1996, č. 4, s. 220-235.
38. Napoli, C., Glass, C. K., Witztum, J. L. et al.: Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet, 354 (9186), 1999, s. 1234-1241.
39. Nappo, F., De Rosa, N., Marfella, R. et al.: Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by anti-oxidant vitamins. JAMA, 281, 1999, č. 22, s. 2113-2118.
40. Newman, W. P., Freeman, D. S., Voors, A. V.: Relations of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. New Engl. J. Med., 314, 1986, č. 3, s. 138-148.
41. Owen, E. P., Human, L., Carolissen, A. A. et al.: Hyperhomocysteinemia - a risk factor for abruptio placentae. J. Inherit. Metab. Dis., 20, 1999, č. 3, s. 359-362.
42. Palyzová, D., Nováková, I., Bendlová, B. a spol.: Metabolismus glukózy, inzulinu a lipidů u juvenilní hypertenze a v prehypertenzivním stadiu. Čs. Pediat., 51, 1996, č. 12, s. 715-724.
43. Perry, I. J., Whincup, P. H., Shaper, A. G.: Environmental factors in the development of essential hypertension. Brit. Med. Bull., 50, 1994, č. 2, s. 246-259.
44. Perry, I. J.: Homocysteine, hypertension and stroke. J. Hum. Hypertension, 13, 1999, č. 5, s. 289-293.
45. Raitakari, T.: Imaging of subclinical atherosclerosis in children and young adults. Ann. Med., 31, 1999, Suppl. 1, s. 33-40.
46. Seekl, J. R.: Glucocorticoids, feto-placental 11-beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids, 62, 1997, č. 1, s. 89-94.
47. Sharabi, Y., Doolman, R., Rosenthal, T. et al.: Homocysteine levels in hypertensive patients with a history of cardiac or cerebral atherothrombotic events. Amer. J. Hypertension, 12, 1999, č. 8, Pt 1, s. 766-771.
48. Sheu, W. H., Lee, W. J., Chen, Y. T.: Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. Amer. J. Hypertension, 13, 2000, č. 1, Pt 1, s. 14-20.
49. Shimakawa, T., Nieto, F. J., Malinow, M. R. et al.: Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults. Ann. Epidemiol., 7, 1997, č. 4, s. 285-293.
50. Siewert-Delle, A., Ljungman, S.: The impact of birth weight and gestational age on blood pressure in adult life: a populalion-based study of 49-year-old men. Amer. J. Hypertension, 118, 1998, č. 8, Pt 1, s. 946-953.
51. Stary, H. C., Chandler, A. B., Glagov, S. et al.: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis. American Heart Association. Arteriosclerosis Thrombosis, 14, 1994, č. 5, s. 840-856.
52. Steegers Theunissen, R. P., Boers, G. H., Trijbels, F. J. et al.: Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism, 43, 1994, č. 12, s. 1475-1480.
53. Tanganell, P., Bianciardi, G., Simoes, C. et al.: Distribution of lipid and raised lesions in aortas of young people of different geographic origins (WHO-ISFC PBDAY Study). World Organization-International Society and Federation of Cardiology. Pathobiological Determinants of Atherosclerosis in Youth. Arteriosclerosis Thrombosis, 13, 1993, č. 11, s. 1700-1710.
54. Tonstad, S., Refsum, H., Sivertsen, M. et al.: Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr. Res., 40, 1996, č. 1, s. 47-52.
55. Tonstad, S., Refsum, H., Ueland, P. M.: Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia. Circulation, 96, 1997, č. 6, s. 1803-1808.
56. Tracy, R. E., Newman, W. P. 3rd, Wattigney, W. A. et al.: Risk factors and atherosclerosis in youth autopsy findings of the Bogalusa Heart Study. Amer. J. Med. Sci., 310, 1995, Suppl. 1, s. 37-41.
57. Tracy, R. E., Newman, W. P. 3rd., Wattigney, W. A. et al.: Histologic features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population: the Bogalusa Heart Study. Atherosclerosis, 116, 1995, č. 2, s. 163-179.
58. Tsai, J. C., Perrella, M. A., Yoshizumi, H. et al.: Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Nat. Acad. Sci. USA, 91, 1994, č. 14, s. 6369-6373.
59. Ubbink, J. B., Vemaak, W. J. H., van der Merwe, A. et al.: Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutrition, 124, 1994, č. 10, s. 1927-1933.
60. Ubbink, J. B., van der Merwe, A., Delport, R. et al.: The effect of a subnormal vitamin B-6 status on homocysteine metabolisms. J. Clin. Invest., 98, 1996, č. 1, s. 177-184.
61. Uiterwaal, C. S., Anthony, S., Launer, L. J. et al.: Birth weight, growth, and blood pressure: an annual follow-up study of children aged 5 through 21 years. Hypertension, 30, 1997, č. 2, Pt 1, s. 267-271.
62. Valtonen, V. V.: Role of infections in atherosclerosis. Amer. Heart J., 138, 1999, č. 5, Pt 2, s. 431-433.
63. van den Berg, M., Franken, D. G., Boers, G. H. et al.: Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J. Vasc. Surg., 20, 1994, č. 6, s. 933-940.
64. van den Griend, R., Haas, F. J., Duran, M. et al.: Methionine loading test is necessary for detection of hyperhomocysteinemia. J. Lab. Clin. Med., 132, 1998, č. 1, s. 67-72.
65. van-Dusseldorp, M., Schneede, J., Refsum, H. et al.: Risk of persistent cobalamin deficiency in adolescents fed a macrobiotic diet in early life. Amer J. Clin. Nutrition, 69, 1999, č. 4, s. 664-671.
66. Vanhala, M.: Childhood weight and metabolic disease on adults. Ann. Med., 31, 1999, č. 4, s. 236-239.
67. Vilaseca, M. A., Moyano, D., Ferrer, I. et al.: Total homocysteine in pediatric patients. Clin. Chem., 43, 1999, č. 4, s. 690-691.
68. Woo, K. S., Chook, P., Lolin, Y. I. et al.; Folic acid improves arterial endothelial function in adult with hyperhomocysteinemia. J. Amer. Coll. Cardiol., 34, 1999, č. 7, s. 2002-2006.
69. Wouters, M. G. A. J., Boers, G. H. J., Blom, H. J. et al.: Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil. Steril., 60, 1993, č. 5, s. 820-825.
70. Wu, L. L., Wu, J., Hunt, S. C. et al.: Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin. Chem., 40, 1994, č. 4, s. 552-561.